ClinicalTrials.gg
CompletedNCT03413540Updated Jul 26, 2019

Effects of Jumping on Bone Health in Young Women

An interventional study of Jump in Osteoporosis, Osteopenia, sponsored by California State University, San Marcos. Completed. Open to female participants aged 18 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-26.

Sponsored by California State University, San Marcos · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 9 years 3 months after the study started (first participant enrolled Sep 2008, registered Jan 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
357
Allocation
Randomized
Ages
18 Years to 42 Years
Sex
Female
01

Study summary

This study evaluates the longitudinal, dose-dependent effects of jumping on bone health in young women. The women will be divided into 9 groups of varying jump height and repetitions, with a tenth group serving as control.

Read the detailed description

Over 1 million hip and spine fractures each year are associated with osteoporosis, a disease of low bone mass that contributes to increased morbidity, mortality and economic strain on our medical system. Effective low-cost prevention strategies such as bone-loading exercise, could lower the incidence of osteoporotic fractures without an increase in medical costs, and provide an alternative to drug therapy. Activity associated with high magnitude forces such as fast running and jumping, have been shown to increase hip bone mass by 1.2%-4% in premenopausal women which may translate into a 20-30% reduction in hip fracture risk. In addition, high impact exercise may also produce benefits that are maintained long-term. However, a specific exercise prescription for improving bone health has not been determined.

To date, no single study has examined the interactive effects of jump magnitude (height) and jump number (repetitions) on bone mineral density by systematically varying the height and number of jumps performed. In addition, no study has evaluated the effects of loading exercise on multiple measures of bone health, in order to quantify the effects of exercise on bone strength, apart from bone mineral density. Determining the optimal dose of jump exercise for improving bone strength will allow the investigators to determine a specific exercise prescription for bone health in premenopausal women and will be useful in future projects that intend to employ jump training to target bone health. The long-term objective of this line of research is to determine how impact loading improves bone quality to ultimately reduce fracture risk.

This study is a randomized, controlled, trial to compare the effects of a 9-month supervised exercise program using three levels of load magnitude (4", 8", 12" jump height) and three load repetitions (10, 50, 100 jumps per session), on three dimensions of bone health (bone density, remodeling and strength) in 300 premenopausal women aged 18-42y. Bone density is the most widely recognized dimension of bone health and clinically accepted index of fracture risk. Bone remodeling reflects the dynamic state of bone and can predict fracture risk independent of bone density. Bone strength, represented by Femur Strength Index, is a reflection of the geometry and structural competence of bone.

Low-cost osteoporosis prevention strategies including jumping exercises, could lower the incidence of osteoporotic fractures without an increase in medical costs, and provide an alternative to drug therapy. This project will allow the investigators to determine the minimum effective dose of jumping exercise required to benefit bone health in premenopausal women and will lead to future research on how exercise improves bone quality and reduces fracture risk.

02

Conditions studied

  • Osteoporosis, Osteopenia

Keywords

  • jumping
  • bone health
03

In context

Osteoporosis

1,601 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.

This study's enrollment of 357 is above the median of 88 across 1,084 interventional studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

California State University, San Marcos is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Premenopausal with a history of regular menses (10-12 cycles/year)

Exclusion criteria

Exclusion Criteria:

  • Current smoking
  • Obesity ( > 30 kg/m2) or underweight (BMI \< 18 kg/m2)
  • Use of medications known to affect bone metabolism including thyroid hormone, thiazide diuretics, aromatase inhibitors, hormone replacement therapy, selective estrogen receptor modulators (SERMS) and bisphosphonates within the previous 6 months. (Note: Women currently using hormonal (e.g. estrogen, progesterone, depot medroxyprogesterone acetate) for at least the previous 12 months will not be excluded from participation, but will be asked to continue with their current method throughout the study period).
  • Chronic disorders that affect bone metabolism and/or the ability to participate in exercise training such as diabetes, hyperparathyroidism, uncontrolled hypothyroidism, balance difficulties, use of narcotic medication.
  • Regular participation in exercise associated with a large volume of jumping (i.e., volleyball, basketball, high-impact aerobics, plyometrics, gymnastics, etc) within the past year.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
357 participants (actual)

Study arms

  • Experimental
    Group 1

    10-cm step, 10 reps

    Other: Jump

  • Experimental
    Group 2

    10-cm step, 50 reps

    Other: Jump

  • Experimental
    Group 3

    10-cm step, 100 reps

    Other: Jump

  • Experimental
    Group 4

    20-cm step, 10 reps

    Other: Jump

  • Experimental
    Group 5

    20-cm step, 50 reps

    Other: Jump

  • Experimental
    Group 6

    20-cm step, 100 reps

    Other: Jump

  • Experimental
    Group 7

    30-cm step, 10 reps

    Other: Jump

  • Experimental
    Group 8

    30-cm step, 50 reps

    Other: Jump

  • Experimental
    Group 9

    30-cm step, 100 reps

    Other: Jump

  • No intervention
    Group 10

    Control

Interventions

  • OtherJump

    Drop jump from step

06

What researchers measure

Primary outcomes

  1. Bone mineral density

    Bone mineral density using dual-energy X-ray absorptiometry (DXA)

    Time frame: Change from baseline bone mineral density at 9 months

Secondary outcomes

  1. Bone remodeling

    Bone formation and resorption markers in blood

    Time frame: Change from baseline bone formation and resorption markers at 9 months

  2. Bone strength

    Femur strength Index (FSI) calculated from DXA scan

    Time frame: Change from baseline femur strength index at 9 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2008 to primary completion in Jun 2012, 44 months.

Of 219 non-industry interventional studies with no phase under Osteoporosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 49. This study's 44 months is above that.

Counting every sponsor, half of 238 studies reached it within 26 months; a quarter within 9 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2018
First posted
Jan 29, 2018
StartActual
Sep 28, 2008
Primary completionActual
Jun 13, 2012
CompletionActual
Jun 13, 2012
Last update
Jul 26, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03413540
Lead sponsor
California State University, San Marcos
Responsible party
Kara Witzke (Professor, Kinesiology, California State University, San Marcos) — Principal investigator
First posted
Jan 29, 2018
Start date
Sep 28, 2008
Primary completion
Jun 13, 2012
Completion
Jun 13, 2012
Last update
Jul 26, 2019

Study contacts

Kara A Witzke, PhD
principal investigator · Oregon State University - Cascades

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion